Gilead Stock Forecast Zacks
The technique has proven to be very useful for finding positive surprises. Gilead sciences (gild) came out with quarterly earnings of $2.65 per share, beating the zacks consensus estimate of $1.72 per share.
According to the issued ratings of 15 analysts in the last year, the consensus rating for gilead sciences stock is buy based on the current 5 hold ratings and 10 buy ratings for gild.
Gilead stock forecast zacks. Six analysts surveyed by zacks expected $6.23 billion. Simply put, stocks with a zacks rank of 1, 2, or 3, with a positive esp were shown to positively surprise 70% of the time. The views and opinions expressed herein are the views and opinions of the author and do not.
In fact, when combining a zacks rank #3 or better and a positive earnings esp, stocks produced a positive surprise 70% of. Collectively, these companies sit at #1 in the zacks sector rank. Their forecasts range from $66.00 to $625.00.
That means the average analyst price target for gild stock is $75.99. The hiv and hepatitis c drugmaker posted revenue of $7.42 billion in the period, which also topped street forecasts. This compares to earnings of $2.11 per share a year ago.
For the gilead sciences inc forecast (traded under symbol gild) for one year forward price target at the top of this page, we have presented the average gild forecast for forward target price across the 15 analysts covering gild, as reported in data provided by zacks investment research via quandl.com. Gilead currently carries a zacks rank #3 (hold). Free stock analysis report to read this article on zacks.com click here.
You can see the complete list of today’s zacks #1 (strong buy) rank stocks here. The zacks sector rank considers 16 different sector. On average, they expect gilead sciences' share price to reach $124.58 in the next twelve months.
This suggests a possible upside of 76.4% from the stock's current price. Last year's 2020 zacks top 10 stocks. Besides its coronavirus efforts, gilead is trying to stake its claim in hiv treatments.
Gild | complete gilead sciences inc. The low price target for gild is. Based on gild analyst price targets, gild stock forecast is $75.99 (for a year from now).
Is one of 892 individual stocks in the medical sector. This quarterly report represents an earnings surprise of 54.07%. The prediction is based on 25 analyst estimates.
Posting Komentar untuk "Gilead Stock Forecast Zacks"